Kohli Aditya 4
4 · HilleVax, Inc. · Filed Mar 20, 2024
Insider Transaction Report
Form 4
HilleVax, Inc.HLVX
Kohli Aditya
Director
Transactions
- Sale
Common Stock
2024-03-18$17.66/sh−6,000$105,937→ 819,776 total - Sale
Common Stock
2024-03-19$17.42/sh−6,000$104,492→ 813,776 total - Sale
Common Stock
2024-03-20$164221.00/sh−6,000$985,326,000→ 807,776 total
Footnotes (4)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person October 12, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices between $17.33 and $17.88. The Reporting Person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices between $17.05 and $17.78. The Reporting Person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices between $15.97 and $17.07. The Reporting Person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.